138 related articles for article (PubMed ID: 14704863)
21. Heart disease in diabetic patients.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):372-8. PubMed ID: 16298258
[TBL] [Abstract][Full Text] [Related]
22. Genetics and susceptibility of coronary collateral formation.
Roguin A; Resar JR
Circulation; 2003 Nov; 108(21):e149; author reply e149. PubMed ID: 14638531
[No Abstract] [Full Text] [Related]
23. Haptoglobin: function and polymorphism.
Wassell J
Clin Lab; 2000; 46(11-12):547-52. PubMed ID: 11109501
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 18 and sICAM-1 serum levels in families with type 1 diabetes mellitus.
Mirończuk K; Okruszko A; Wawrusiewicz-Kurylonek N; Kretowski A; Kinalska I; Górska M
Rocz Akad Med Bialymst; 2005; 50():151-4. PubMed ID: 16358956
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of cardiovascular complications in type 2 diabetes mellitus.
Meigs JB
Acta Diabetol; 2003 Dec; 40 Suppl 2():S358-61. PubMed ID: 14704869
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes.
Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hanley AJ; Hegele RA
Cardiovasc Diabetol; 2005 Nov; 4():17. PubMed ID: 16274479
[TBL] [Abstract][Full Text] [Related]
27. Haptoglobin phenotypes in cervical cancer: decreased risk for Hp2-2 individuals.
Quaye IK; Agbolosu K; Ibrahim M; Bannerman-Williams P
Clin Chim Acta; 2009 May; 403(1-2):267-8. PubMed ID: 19296903
[No Abstract] [Full Text] [Related]
28. The genetics of cardiovascular disease.
Delles C; McBride MW; Padmanabhan S; Dominiczak AF
Trends Endocrinol Metab; 2008 Nov; 19(9):309-16. PubMed ID: 18819818
[TBL] [Abstract][Full Text] [Related]
29. Dysglycaemia, cardiovascular outcome and treatment. Is the jury still out?
Bartnik M; Cosentino F
Eur Heart J; 2009 Jun; 30(11):1301-4. PubMed ID: 19395498
[No Abstract] [Full Text] [Related]
30. [The genetics of multifactorial cardiovascular disease. How significant for the cardiologist?].
Bauters C; Lamblin N; Amouyel P
Arch Mal Coeur Vaiss; 2003 Nov; 96(11):1127-30. PubMed ID: 14694791
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa.
Kengne AP; Amoah AG; Mbanya JC
Circulation; 2005 Dec; 112(23):3592-601. PubMed ID: 16330701
[TBL] [Abstract][Full Text] [Related]
33. Health-related disparities: influence of environmental factors.
Olden K; White SL
Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
[TBL] [Abstract][Full Text] [Related]
34. Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
Yosefy C
Acta Diabetol; 2003 Dec; 40 Suppl 2():S380-8. PubMed ID: 14704873
[TBL] [Abstract][Full Text] [Related]
35. Genetic susceptibility to type 2 diabetic nephropathy in human and animal models.
Gohda T; Tanimoto M; Watanabe-Yamada K; Matsumoto M; Kaneko S; Hagiwara S; Shiina K; Shike T; Funabiki K; Tomino Y
Nephrology (Carlton); 2005 Oct; 10 Suppl():S22-5. PubMed ID: 16174283
[TBL] [Abstract][Full Text] [Related]
36. Effect of parental hypertension and/or parental diabetes on hypertension in Taiwanese diabetic patients.
Tseng CH
Eur J Clin Invest; 2007 Nov; 37(11):870-7. PubMed ID: 17973782
[TBL] [Abstract][Full Text] [Related]
37. Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies.
Casas JP; Cooper J; Miller GJ; Hingorani AD; Humphries SE
Ann Hum Genet; 2006 Mar; 70(Pt 2):145-69. PubMed ID: 16626327
[TBL] [Abstract][Full Text] [Related]
38. Diabetic complications and glycaemic control in remote North Africa.
Gill G; Gebrekidan A; English P; Wile D; Tesfaye S
QJM; 2008 Oct; 101(10):793-8. PubMed ID: 18687702
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and cardiovascular disease: explaining the relationship.
Punthakee Z; Werstuck GH; Gerstein HC
Rev Cardiovasc Med; 2007; 8(3):145-53. PubMed ID: 17938614
[TBL] [Abstract][Full Text] [Related]
40. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Blum S; Vardi M; Levy NS; Miller-Lotan R; Levy AP
Atherosclerosis; 2010 Jul; 211(1):25-7. PubMed ID: 20223458
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
